InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,184.08
(
0.06%
)
US TECH 100
17,604.38
(
-0.03%
)
Dow Jones
38,866.16
(
0.04%
)
Brent Oil
83.14
(
-0.41%
)
Bitcoin
63,151.72
(
-0.02%
)
Post# of 869
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

librarianlover

Send PM Follow Ignore
Followers 28
Posts 907
Boards Moderated 0
Alias Born 06/02/2015

librarianlover

Re: The Beyonder post# 15

Tuesday, 08/18/2015 8:24:09 AM

Tuesday, August 18, 2015 8:24:09 AM

Post# of 869
Matinas BioPharma's MAT2203 designated as a Qualified Infectious Disease Product with Fast Track status by the FDA (MTNB) : Matinas BioPharma is developing MAT2203 for the treatment of serious and life-threatening fungal infections in collaboration with the National Institutes of Health/National Institute of Allergy and Infectious Disease. A Phase 2a NIH/NIAID-funded clinical study with MAT2203 in patients with refractory mucocutaneous candidiasis is expected to commence during the third quarter of 2015, with data expected in the first quarter of 2016, or earlier under certain circumstances.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent MTNB News
More MTNB News
InvestorsHub NewsWire

FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM

Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Start posting your company's news
Only $200 per official company press release!